Dexamethasone Treatment Options

A collection of 1458 research studies where Dexamethasone is the interventional treatment. These studies are located in the United States. Dexamethasone is used for conditions such as Multiple Myeloma, Postoperative Pain and Lymphoma.

Home

All Treatments

Dexamethasone

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Offer

Lose Weight with GLP-1 Medications

Recruiting

Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.

As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

BrECADD Therapy in Stage 2 B-IV Hodgkin Lymphoma

NCT07002216

Recruiting

The purpose of this study is to further assess the efficacy and tolerability of a regimen of Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine, and Dexamethasone (BrECADD) in patients with Stage 2 B-IV Hodgkin Lymphoma (HL) with an exploratory objective to assess the clinical utility of Circulating tumor DNA (ctDNA) as a biomarker for minimal residual disease (MRD) and depth of treatment response.

Gender:

ALL

Ages:

Between 18 years and 60 years

Trial Updated:

07/07/2025

Locations: University of Miami, Miami, Florida

Conditions: Hodgkin Lymphoma, Advanced Hodgkin Lymphoma

Learn More ›

Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

NCT04975997

Active Not Recruiting

This is a multicenter, two-stage, randomized, controlled, open-label, Phase 3 study comparing the efficacy and safety of iberdomide in combination with dexamethasone and daratumumab (IberDd) versus daratumumab, bortezomib, and dexamethasone (DVd) in participants with relapsed or refractory multiple myeloma (RRMM).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/07/2025

Locations: Local Institution - 035, Hot Springs, Arkansas +258 locations

Local Institution - 035, Hot Springs, Arkansas

Local Institution - 641, Cerritos, California

Local Institution - 681, Fountain Valley, California

Local Institution - 047, Los Angeles, California

Local Institution - 684, Newport, California

Local Institution - 033, New Haven, Connecticut

Local Institution - 029, Fort Myers, Florida

Local Institution - 693, Ocala, Florida

Local Institution - 028, Saint Petersburg, Florida

Local Institution - 045, Tamarac, Florida

Local Institution - 034, West Palm Beach, Florida

Local Institution - 685, Weston, Florida

Local Institution - 018, Atlanta, Georgia

Local Institution - 640, Elk Grove Village, Illinois

Local Institution - 697, Dyer, Indiana

Local Institution - 040, Louisville, Kentucky

Local Institution - 041, Alexandria, Louisiana

Local Institution - 682, Baton Rouge, Louisiana

Local Institution - 027, Baton Rouge, Louisiana

Local Institution - 698, Baltimore, Maryland

Local Institution - 014, Bethesda, Maryland

Local Institution - 688, Columbia, Maryland

Local Institution - 010, Boston, Massachusetts

Local Institution - 009, Worcester, Massachusetts

Local Institution - 645, Burnsville, Minnesota

Local Institution - 031, Kansas City, Missouri

Local Institution - 046, Billings, Montana

Local Institution - 015, Summit, New Jersey

Local Institution - 691, New York, New York

Local Institution - 039, Durham, North Carolina

Local Institution - 038, Cincinnati, Ohio

Local Institution - 037, Cleveland, Ohio

Local Institution - 008, Cleveland, Ohio

Local Institution - 036, Columbus, Ohio

Local Institution - 680, Tulsa, Oklahoma

Local Institution - 043, Portland, Oregon

Local Institution - 030, Chattanooga, Tennessee

Local Institution - 021, Nashville, Tennessee

Local Institution - 687, Austin, Texas

Local Institution - 695, Houston, Texas

Local Institution - 642, Newport News, Virginia

Local Institution - 643, Roanoke, Virginia

Local Institution - 025, Madison, Wisconsin

Local Institution - 080, Ciudad Autanoma De Buenos Aires, Buenos Aires

Local Institution - 083, Villa Elisa, Buenos Aires

Local Institution - 813, Birtinya, Queensland

Local Institution - 812, Douglas, Queensland

Local Institution - 803, Adelaide, South Australia

Local Institution - 806, Bedford Park, South Australia

Local Institution - 802, Clayton, Victoria

Local Institution - 809, East Melbourne, Victoria

Local Institution - 801, Melbourne, Victoria

Local Institution - 811, Murdoch, Western Australia

Local Institution - 807, West Perth, Western Australia

Local Institution - 804, Camperdown, Not set

Local Institution - 800, Fitzroy, Not set

Local Institution - 808, Garran, Not set

Local Institution - 155, Graz, Not set

Local Institution - 154, Linz, Not set

Local Institution - 153, Salzburg, Not set

Local Institution - 156, St Polten, Not set

Local Institution - 150, Vienna, Not set

Local Institution - 151, Wien, Not set

Local Institution - 172, Brugge, Not set

Local Institution - 174, Bruxelles, Not set

Local Institution - 056, Curitiba, Parana

Local Institution - 058, Porto Alegre, RIO Grande DO SUL

Local Institution - 050, Porto Alegre, RS

Local Institution - 054, Jau, SAO Paulo

Local Institution - 055, Sao Paulo, SP

Local Institution - 051, Barretos, São Paulo

Local Institution - 053, Rio de Janeiro, Not set

Local Institution - 057, Sao Paulo, Not set

Local Institution - 052, Sao Paulo, Not set

Local Institution - 111, Calgary, Alberta

Local Institution - 103, Edmonton, Alberta

Local Institution - 112, Surrey, British Columbia

Local Institution - 104, Saint John, New Brunswick

Local Institution - 110, St John's, Newfoundland and Labrador

Local Institution - 101, Halifax, Nova Scotia

Local Institution - 109, Ottawa, Quebec

Local Institution - 107, Saskatoon, Saskatchewan

Local Institution - 108, Quebec, Not set

Local Institution - 141, Changsha, Hunan

Local Institution - 129, Nanchang, Jiangxi

Local Institution - 143, Xian, Shaanxi

Local Institution - 142, Shanghai, Shanghai

Local Institution - 145, Taiyuan, Shanxi

Local Institution - 144, Wenzhou, Zhejiang

Local Institution - 140, Beijing, Not set

Local Institution - 139, Beijing, Not set

Local Institution - 138, Beijing, Not set

Local Institution - 126, Changchun, Not set

Local Institution - 121, Chaoyang District, Not set

Local Institution - 135, Guangzhou, Not set

Local Institution - 136, Guangzhou, Not set

Local Institution - 128, Hangzhou City, Not set

Local Institution - 120, Hangzhou, Zhejiang, Not set

Local Institution - 127, Harbin, Not set

Local Institution - 134, Nanjing, Not set

Local Institution - 132, Shanghai, Not set

Local Institution - 130, Shanghai, Not set

Local Institution - 131, Shenyang, Not set

Local Institution - 124, Suzhu, Not set

Local Institution - 133, Tianjin, Not set

Local Institution - 137, Wuhan, Not set

Local Institution - 125, Xian, Not set

Local Institution - 123, Zhengzhou, Not set

Local Institution - 601, Brno, Not set

Local Institution - 600, Ostrava-Poruba, Not set

Local Institution - 602, Prague 2, Not set

Local Institution - 371, Aalborg, Not set

Local Institution - 370, Odense, Not set

Local Institution - 372, Roskilde, Not set

Local Institution - 231, Turku, Varsinais-Suomi

Local Institution - 230, Helsinki, Not set

Local Institution - 232, Oulu, Not set

Local Institution - 463, Argenteuil, Not set

Local Institution - 462, La Roche -Sur-Yon - Cedex 9, Not set

Local Institution - 451, Lille Cedex, Not set

Local Institution - 458, Nancy Cedex, Not set

Local Institution - 454, Nantes, Not set

Local Institution - 452, Paris Cedex, Not set

Local Institution - 456, Paris, Not set

Local Institution - 464, Pessac, Not set

Local Institution - 465, Rouen, Not set

Local Institution - 457, Toulouse Cedex 9, Not set

Local Institution - 308, Kiel, Schleswig-Holstein

Local Institution - 301, Frankfurt am Main, Not set

Local Institution - 300, Hamburg, Not set

Local Institution - 302, Hamburg, Not set

Local Institution - 305, Heidelberg, Not set

Local Institution - 304, Lubeck, Not set

Local Institution - 573, Patras, Achaea

Local Institution - 574, Patra, Achaia

Local Institution - 571, Athens, Not set

Local Institution - 572, Thessaloniki, Not set

Local Institution - 570, Thessaloniki, Not set

Local Institution - 932, Hyderabad, Andhra Pradesh

Local Institution - 930, Bangalore, Karnataka

Local Institution - 934, Ernakulam, Kerala

Local Institution - 933, Mumbai, Maharashtra

Local Institution - 935, Kolkata, West Bengal

Local Institution - 931, Pondicherry, Not set

Local Institution - 752, Cork, Not set

Local Institution - 750, Dublin 9, Not set

Local Institution - 751, Galway, Not set

Local Institution - 874, Afula, HaZafon

Local Institution - 872, Haifa, Not set

Local Institution - 871, Jerusalem, Not set

Local Institution - 870, Tel Aviv, Not set

Local Institution - 873, Tel Hashomer, Not set

Local Institution - 415, Roma, Lazio

Local Institution - 400, Bologna, Not set

Local Institution - 408, Catania, Not set

Local Institution - 414, Genova, Not set

Local Institution - 404, Milano, Not set

Local Institution - 410, Novara, Not set

Local Institution - 412, Pavia, Not set

Local Institution - 402, Pisa, Not set

Local Institution - 405, Reggio Calabria, Not set

Local Institution - 401, Roma, Not set

Local Institution - 403, San Giovanni Rotondo FG, Not set

Local Institution - 406, Udine, Not set

Local Institution - 900, Matsuyama, Ehime

Local Institution - 917, Higashi-Ibaraki-gun, Ibaraki

Local Institution - 919, Shimotsuga, Tochigi

Local Institution - 920, Nerima-ku, Tokyo

Local Institution - 918, Shinagawa-ku, Tokyo

Local Institution - 915, Chuo-shi, Yamanashi

Local Institution - 912, Aomori, Not set

Local Institution - 916, Chiba, Not set

Local Institution - 911, Fukuoka, Not set

Local Institution - 903, Kamogawa, Not set

Local Institution - 902, Kyoto-City, Not set

Local Institution - 910, Nagoya, Not set

Local Institution - 901, Nagoya, Not set

Local Institution - 905, Okayama, Not set

Local Institution - 908, Osaka-Sayama, Not set

Local Institution - 907, Osaka, Not set

Local Institution - 913, Sapporo, Not set

Local Institution - 914, Sendai, Not set

Local Institution - 906, Shibuya-ku, Not set

Local Institution - 909, Shinagawa-ku, Tokyo, Not set

Local Institution - 904, Toyohashi, Not set

Local Institution - 974, Daegu, Not set

Local Institution - 973, Gyeonggi-do, Not set

Local Institution - 975, Hwasun-gun, Not set

Local Institution - 971, Seoul, Not set

Local Institution - 976, Seoul, Not set

Local Institution - 972, Seoul, Not set

Local Institution - 970, Seoul, Not set

Local Institution - 977, Seoul, Not set

Local Institution - 183, Guadalajara, Jalisco

Local Institution - 351, Dordrecht, Zuid-Holland

Local Institution - 354, Amsterdam, Not set

Local Institution - 352, Den Haag, Not set

Local Institution - 202, Bergen, Not set

Local Institution - 200, Oslo, Not set

Local Institution - 201, Trondheim, Not set

Local Institution - 631, Bialystok, Podlaskie

Local Institution - 633, Krakow, Not set

Local Institution - 635, Nowy Sacz, Not set

Local Institution - 634, Poznan, Not set

Local Institution - 636, Walbrzych, Not set

Local Institution - 630, Warszawa, Not set

Local Institution - 545, Coimbra, Not set

Local Institution - 543, Lisboa, Not set

Local Institution - 544, Lisboa, Not set

Local Institution - 540, Porto, Not set

Local Institution - 541, Porto, Not set

Local Institution - 514, Pamplona, Navarra

Local Institution - 505, Barcelona, Not set

Local Institution - 502, Barcelona, Not set

Local Institution - 511, Barcelona, Not set

Local Institution - 501, Caceres, Not set

Local Institution - 509, Cordoba, Not set

Local Institution - 510, Madrid, Not set

Local Institution - 516, Madrid, Not set

Local Institution - 504, Madrid, Not set

Local Institution - 513, Madrid, Not set

Local Institution - 503, Malaga, Not set

Local Institution - 508, Murcia, Not set

Local Institution - 506, Oviedo, Not set

Local Institution - 515, Salamanca, Not set

Local Institution - 500, Santiago de Compostela, Not set

Local Institution - 512, Valencia, Not set

Local Institution - 507, Zaragoza, Not set

Local Institution - 272, Boras, Not set

Local Institution - 271, Helsingborg, Not set

Local Institution - 851, Chur, Not set

Local Institution - 850, St. Gallen, Not set

Local Institution - 955, Niao-Sung Hsiang Kaohsiung County, Not set

Local Institution - 952, Taichung City, Not set

Local Institution - 954, Taichung, Not set

Local Institution - 951, Tainan, Taiana, Not set

Local Institution - 956, Taipei, Zhongzheng Dist., Not set

Local Institution - 950, Taipei, Not set

Local Institution - 953, Taoyuan City, Not set

Local Institution - 778, Kavaklıdere, Ankara

Local Institution - 776, Yenimahalle, Ankara

Local Institution - 777, Pendik, Istanbul

Local Institution - 771, Balçova, Izmir

Local Institution - 775, Bornova, Izmir

Local Institution - 773, Samsun, Kurupelit

Local Institution - 770, Ankara, Not set

Local Institution - 772, Gaziantep, Not set

Local Institution - 774, Kayseri, Not set

Local Institution - 702, Nottingham, Nottinghamshire

Local Institution - 705, Belfast Northern Ireland, Not set

Local Institution - 700, Birmingham, Not set

Local Institution - 707, Canterbury Kent, Not set

Local Institution - 704, Lancashire Blackpool, Not set

Local Institution - 701, London, Not set

Local Institution - 709, London, Not set

Local Institution - 706, Oxford, Not set

Local Institution - 711, Portsmouth, Not set

Local Institution - 713, Sutton, Not set

Local Institution - 708, Wolverhampton, Not set

Conditions: Multiple Myeloma

Learn More ›

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

NCT05651932

Recruiting

A Phase I study to evaluate the safety of a novel, orally available, selective, and potent small molecule inhibitor of the histone lysine methyl transferase MMSET (also known as NSD2/WHSC1) to prevent the dimethylation of H3K36 in adult patients with relapsed or refractory multiple myeloma (RRMM).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/07/2025

Locations: UCSF Medical Center - Hematology and Blood and Marrow Transplant Clinic, San Francisco, California +20 locations

UCSF Medical Center - Hematology and Blood and Marrow Transplant Clinic, San Francisco, California

Mayo Clinic Hospital - Florida, Jacksonville, Florida

The Winship Cancer Institute of Emory University, Atlanta, Georgia

Massachusetts General Hospital, Boston, Massachusetts

Mayo Clinic - Transplant Center - Rochester, Rochester, Minnesota

Hackensack University Medical Center, Hackensack, New Jersey

Memorial Sloan-Kettering Cancer Center, New York, New York

Atrium Health, Levine Cancer Institute, Charlotte, North Carolina

Duke University Hospital, Durham, North Carolina

University of Pennsylvania, Philadelphia, Pennsylvania

Tennessee Oncology, Nashville, Tennessee

University of Texas Southwestern Harold C. Simmons Comprehensive Cancer Center, Dallas, Texas

University Health Network (UHN) - Princess Margaret Cancer Centre (Princess Margaret Hospital), Toronto, Ontario

Centre Hospitalier Universitaire de Nantes (CHU de Nantes) - Hotel-Dieu, Nantes, Not set

Centre Hospitalier Universitaire de Poitiers (CHU de Poitiers), Poitiers, Not set

Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, Not set

Universitaire de Lille, Villeneuve-d'Ascq, Not set

Clínica Universidad de Navarra, Pamplona, Navarra

Hospital ClÃ-nic de Barcelona, Barcelona, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Instituto de Investigacion Biomedica de Salamanca (IBSAL), Salamanca, Not set

Conditions: Multiple Myeloma, Myeloma, Myeloma Multiple

Learn More ›

A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma

NCT03290950

Active Not Recruiting

This is a study to test the safety and effectiveness of the study drug, daratumumab in combination with carfilzomib, lenalidomide and dexamethasone. The purpose of this study is to test whether giving daratumumab along with the other drugs (carfilzomib, lenalidomide and dexamethasone) is safe for patients.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/07/2025

Locations: Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey +6 locations

Conditions: Multiple Myeloma

Learn More ›

Isa-Pom-Dex in Elderly/Frail Subjects With RRMM

NCT05911321

Active Not Recruiting

This research study aims to evaluate the safety and effectiveness of the combination of isatuximab, pomalidomide, and dexamethasone (Isa-Pd) for the treatment of relapsed or refractory multiple myeloma (RRMM), which refers to multiple myeloma that has returned or has not responded to prior treatment. The study will specifically investigate the impact of administering lower-than-standard doses of pomalidomide and dexamethasone. Using lower doses of pomalidomide and dexamethasone in this setting h... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/06/2025

Locations: Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina +1 locations

Conditions: Multiple Myeloma, Relapse, Refractory, Aging, Co-morbidity

Learn More ›

Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)

NCT02861573

Recruiting

The purpose of this study is to assess the safety and efficacy of pembrolizumab (MK-3475) combination therapy in participants with metastatic castration resistant prostate cancer (mCRPC). There will be ten cohorts in this study: Cohort A will receive pembrolizumab + olaparib, Cohort B will receive pembrolizumab + docetaxel + prednisone, Cohort C will receive pembrolizumab + enzalutamide, Cohort D will receive pembrolizumab + abiraterone + prednisone Cohort E will receive pembrolizumab+lenvatinib... Read More

Gender:

MALE

Ages:

18 years and above

Trial Updated:

07/04/2025

Locations: Call for Information (Investigational Site 0005), Los Angeles, California +25 locations

Call for Information (Investigational Site 0005), Los Angeles, California

Call for Information (Investigational Site 2041), Aurora, Colorado

Call for Information (Investigational Site 2083), Baltimore, Maryland

Call for Information (Investigational Site 2091), Cleveland, Ohio

Call for Information (Investigational Site 2027), Portland, Oregon

Call for Information (Investigational Site 2094), Portland, Oregon

Call for Information (Investigational Site 0008), Pittsburgh, Pennsylvania

Call for Information (Investigational Site 2065), Charleston, South Carolina

Call for Information (Investigational Site 0016), Seattle, Washington

MSD Australia, North Ryde, Not set

Merck Canada, Kirkland, Quebec

MSD Denmark, Glostrup, Not set

MSD Finland Oy, Espoo, Not set

MSD France, Paris, Not set

MSD Sharp & Dohme GmbH, München, Not set

MSD Ireland (Human Health) Ltd., Dublin, Not set

MSD Italia S.r.l., Rome, Not set

MSD Comercializadora, S. de R.L. de C.V., Mexico City, Not set

Merck Sharp & Dohme BV, Haarlem, Not set

Merck Sharp & Dohme (New Zealand) Ltd.,, Auckland, Not set

MSD Polska Sp. Z o.o., Warsaw, Not set

Merck Sharp and Dohme de Espana S.A., Madrid, Not set

MSD Sweden, Stockholm, Not set

Merck Sharp & Dohme (I.A.) Corp., Taipei, Not set

Merck Sharp & Dohme Ilaclari Ltd. Sti, Istanbul, Not set

Merck Sharp & Dohme Ltd., London, Not set

Conditions: Metastatic Castration-Resistant Prostate Cancer

Learn More ›

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

NCT06136624

Active Not Recruiting

This is a phase 3, randomized, open-label study of opevesostat compared to alternative abiraterone acetate or enzalutamide in participants with metastatic castration-resistant prostate cancer (mCRPC) with respect to overall survival (OS) and to radiographic progression-free survival (rPFS) per Prostate Cancer Working Group (PCWG) Modified Response Evaluation Criteria In Solid Tumors (RECIST 1.1) as assessed by blinded independent central review (BICR) in participants with mCRPC previously treate... Read More

Gender:

ALL

Ages:

All

Trial Updated:

07/03/2025

Locations: University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0040), Orange, California +278 locations

University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0040), Orange, California

Stanford Cancer Center ( Site 0036), Palo Alto, California

Kaiser Permanente Riverside Medical Center ( Site 0099), Riverside, California

Anschutz Cancer Pavilion ( Site 0046), Aurora, Colorado

University of Colorado Health - Highlands Ranch Hospital ( Site 0111), Highlands Ranch, Colorado

Colorado Clinical Research ( Site 0067), Lakewood, Colorado

University of Colorado Health - Lone Tree Medical Center ( Site 0112), Lone Tree, Colorado

Yale-New Haven Hospital-Yale Cancer Center ( Site 0064), New Haven, Connecticut

Florida Cancer Specialists - South ( Site 7003), Fort Myers, Florida

Bruce W. Carter Veterans Affairs Medical Center ( Site 0082), Miami, Florida

University of Miami Hospital and Clinics, Sylvester Cancer Center ( Site 0051), Miami, Florida

University of Illinois at Chicago ( Site 0105), Chicago, Illinois

University of Chicago Medical Center ( Site 0045), Chicago, Illinois

University of Iowa ( Site 0047), Iowa City, Iowa

University of Kentucky Chandler Medical Center ( Site 0048), Lexington, Kentucky

Ochsner Clinic Foundation ( Site 0108), New Orleans, Louisiana

Baltimore Veterans Affairs Medical Center ( Site 0069), Baltimore, Maryland

Greenebaum Comprehensive Cancer Center ( Site 0049), Baltimore, Maryland

Henry Ford Hospital ( Site 0015), Detroit, Michigan

M Health Fairview Clinics and Surgery Center ( Site 0019), Minneapolis, Minnesota

Metro-Minnesota Community Clinical Oncology ( Site 0014), Saint Louis Park, Minnesota

Washington University School of Medicine-Internal Medicine/Oncology ( Site 0062), Saint Louis, Missouri

University Of Nebraska Medical Center-Oncology/Hematology ( Site 0095), Omaha, Nebraska

Comprehensive Cancer Centers of Nevada ( Site 0010), Las Vegas, Nevada

Atlantic Health System Morristown Medical Center ( Site 0115), Morristown, New Jersey

Rutgers Cancer Institute of New Jersey ( Site 0033), New Brunswick, New Jersey

James J. Peters VA Medical Center ( Site 0088), Bronx, New York

University Hospitals Cleveland Medical Center ( Site 0043), Cleveland, Ohio

Oregon Health and Science University ( Site 0028), Portland, Oregon

VA Portland Health Care System ( Site 0058), Portland, Oregon

AHN Allegheny General Hospital ( Site 0001), Pittsburgh, Pennsylvania

Ralph H. Johnson VA Health Care System (RHJVAHCS)-Urology ( Site 0083), Charleston, South Carolina

Avera Cancer Institute - Pierre ( Site 0118), Pierre, South Dakota

Avera Cancer Institute- Research ( Site 0094), Sioux Falls, South Dakota

Avera Cancer Institute - Yankton ( Site 0117), Yankton, South Dakota

SCRI Oncology Partners ( Site 7000), Nashville, Tennessee

Texas Oncology - Central/South Texas ( Site 8003), Austin, Texas

Texas Oncology - DFW ( Site 8001), Dallas, Texas

Texas Oncology - Gulf Coast ( Site 8002), The Woodlands, Texas

University of Virginia Health System ( Site 0054), Charlottesville, Virginia

VCU Health Adult Outpatient Pavillion ( Site 0061), Richmond, Virginia

Blue Ridge Cancer Care ( Site 0004), Roanoke, Virginia

Fred Hutchinson Cancer Center ( Site 0013), Seattle, Washington

MEDICAL COLLEGE OF WISCONSIN ( Site 0020), Milwaukee, Wisconsin

Hospital Británico de Buenos Aires-Oncology ( Site 0202), Ciudad autónoma de Buenos Aires, Buenos Aires

Instituto de Investigaciones Clínicas Mar del Plata ( Site 0201), Mar del Plata, Buenos Aires

Asociación de Beneficencia Hospital Sirio Libanés ( Site 0205), Buenos Aires, Caba

Instituto Alexander Fleming-Alexander Fleming ( Site 0206), Ciudad Autónoma de Buenos Aires, Caba

Sanatorio Parque ( Site 0208), Rosario, Santa Fe

Hospital Aleman-Oncology ( Site 0207), Buenos Aires, Not set

Fundacion Centro Oncologico de Integración Regional-Medical Oncology ( Site 0204), Mendoza, Not set

Dubbo Hospital ( Site 0235), Dubbo, New South Wales

Macquarie University-MQ Health Clinical Trials Unit ( Site 0234), Macquarie University, New South Wales

Westmead Hospital ( Site 0232), Westmead, New South Wales

Princess Alexandra Hospital-Cancer Care Serices ( Site 0237), Brisbane, Queensland

Peter MacCallum Cancer Centre-Parkville Cancer Clinical Trials Unit (PCCTU) ( Site 0230), Melbourne, Victoria

Ordensklinikum Linz GmbH Elisabethinen-Urologie ( Site 0276), Linz, Oberosterreich

Klinikum Wels-Grieskirchen GmbH ( Site 0279), Wels, Oberosterreich

Medizinische Universität Graz-Innere Medizin Klin. Abt. Onkologie ( Site 0280), Graz, Steiermark

Obras Sociais Irma Dulce ( Site 0302), Salvador, Bahia

Hospital Santa Rita de Cassia-Centro de Pesquisa Clínica ( Site 0320), Vitoria, Espirito Santo

Hospital Felicio Rocho ( Site 0317), Belo Horizonte, Minas Gerais

Hospital Mario Penna ( Site 0309), Belo Horizonte, Minas Gerais

Hospital Universitário Evangélico Mackenzie-Centro de Oncologia Mackenzie ( Site 0314), Curitiba, Parana

Clínica de Neoplasias Litoral ( Site 0305), Itajai, Santa Catarina

Hospital Universitário São Francisco de Assis - Bragança Paulista ( Site 0308), Bragança Paulista, Sao Paulo

A. C. Camargo Cancer Center ( Site 0310), São Paulo, Sao Paulo

Cross Cancer Institute ( Site 0332), Edmonton, Alberta

The Ottawa Hospital - General Campus-The Ottawa Hospital Cancer Centre ( Site 0336), Ottawa, Ontario

Sunnybrook Research Institute ( Site 0331), Toronto, Ontario

Princess Margaret Cancer Centre ( Site 0330), Toronto, Ontario

Centre Intégré de Santé et de Services Sociaux de la Montérégie-Centre ( Site 0328), Greenfield Park, Quebec

Centre Hospitalier de l'Université de Montréal ( Site 0326), Montréal, Quebec

Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0327), Quebec City, Quebec

Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Univer ( Site 0329), Sherbrooke, Quebec

IC La Serena Research ( Site 0356), La Serena., Coquimbo

Clinical Research Chile SpA ( Site 0358), Valdivia, Los Rios

Clinica Universidad Catolica del Maule-Oncology ( Site 0355), Talca, Maule

FALP ( Site 0353), Santiago, Region M. De Santiago

Pontificia Universidad Catolica de Chile-Hemato-Oncology ( Site 0354), Santiago, Region M. De Santiago

Bradfordhill-Clinical Area ( Site 0351), Santiago, Region M. De Santiago

Bradford Hill Norte ( Site 0357), Antofagasta, Not set

Second Affiliated hospital of Anhui Medical University-Urology ( Site 0408), Hefei, Anhui

Peking University First Hospital-Urology ( Site 0390), Beijing, Beijing

Beijing Friendship Hospital Affiliate of Capital University ( Site 0396), Beijing, Beijing

Beijing Cancer hospital-Urinary Surgery ( Site 0395), Beijing, Beijing

The First Affiliated Hospital of Chongqing Medical University ( Site 0427), Chongqing, Chongqing

Chongqing University Cancer Hospital ( Site 0416), Chongqing, Chongqing

Southwest Hospital of Third Military Medical University ( Site 0420), Chongqing, Chongqing

Chongqing Three Gorges Central Hospital's ( Site 0426), Chongqing, Chongqing

The First Affiliated Hospital Of Fujian Medical University-Urology ( Site 0414), Fuzhou, Fujian

The First Affiliated hospital of Xiamen University-Urology ( Site 0415), Xiamen, Fujian

The First Affiliated Hospital of Guangzhou Medical University ( Site 0412), Guangzhou, Guangdong

Sun Yat-sen University Cancer Center-Internal medicine ( Site 0413), Guangzhou, Guangdong

Tongji Hospital Tongji Medical,Science & Technology ( Site 0407), Wuhan, Hubei

Hubei Cancer Hospital-Urinary surgery ( Site 0406), Wuhan, Hubei

Hunan Cancer Hospital ( Site 0405), Changsha, Hunan

First Huai'an Hospital Affiliated to Nanjing Medical University ( Site 0436), Huaian, Jiangsu

Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( Site 0377), NanJing, Jiangsu

Affiliated hospital of Jiangnan university ( Site 0434), Wuxi, Jiangsu

Jiangxi Cancer Hospital ( Site 0386), Nanchang, Jiangxi

The Second Affiliated Hospital of Xi'an Jiaotong University ( Site 0394), XI An, Shaanxi

The First Affiliated Hospital of Xi'an Jiaotong University-Oncology ( Site 0393), Xi'an, Shaanxi

Yantai Yuhuangding Hospital ( Site 0397), Yantai, Shandong

Fudan University Shanghai Cancer Center-Urology department ( Site 0376), Shanghai, Shanghai

Huadong Hospital Affiliated to Fudan University-Urology ( Site 0388), Shanghai, Shanghai

West China Hospital, Sichuan University-Urology Surgery ( Site 0417), Cheng Du, Sichuan

The Third People's Hospital of Chengdu (CDTPH) ( Site 0428), Chengdu, Sichuan

Nanchong Central Hospital-urology ( Site 0422), Nanchong, Sichuan

Suining Central Hospital ( Site 0437), Suining, Sichuan

Tianjin Medical University Cancer Institute & Hospital ( Site 0392), Tianjin, Tianjin

The Second Hospital of Tianjin Medical University ( Site 0391), Tianjin, Tianjin

Xinjiang Medical University Cancer Hospital - Urumqi-Urology ( Site 0419), Urumqi, Xinjiang

The Second Affiliated Hospital Of Kunming Medical University ( Site 0429), Kunming, Yunnan

Yunnan Province Cancer Hospital ( Site 0418), Kunming, Yunnan

Zhejiang Provincial People's Hospital-Urology ( Site 0378), Hangzhou, Zhejiang

Zhejiang Cancer Hospital ( Site 0435), Hangzhou, Zhejiang

The First Hospital of Jiaxing-urology ( Site 0380), Jiaxing, Zhejiang

The First Affiliated Hospital of Ningbo University ( Site 0383), Ningbo, Zhejiang

The First Affiliated Hospital of Wenzhou Medical University-Urology Surgery ( Site 0379), Wenzhou, Zhejiang

Sociedad De Oncología y Hematología Del Cesar SAS-Oncology ( Site 0502), Valledupar, Cesar

IMAT S.A.S ( Site 0504), Monteria, Cordoba

Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia-Center Investigator ( Site 0501), Bogota, Distrito Capital De Bogota

Fundación Cardiovascular de Colombia ( Site 0503), Piedecuesta, Santander

Fundación Valle del Lili ( Site 0505), Cali, Valle Del Cauca

Clínica Imbanaco S.A.S ( Site 0509), Cali, Valle Del Cauca

Masarykuv onkologicky ustav-Klinika komplexni onkologicke pece ( Site 0553), Brno, Brno-mesto

Fakultni nemocnice Ostrava-Klinika onkologicka ( Site 0554), Ostrava, Moravskoslezsky Kraj

Fakultni nemocnice Olomouc-Onkologicka klinika ( Site 0555), Olomouc, Olomoucky Kraj

Fakultni nemocnice v Motole-Onkologicka klinika 2. LF UK a FN Motol ( Site 0551), Praha, Praha 5

Rigshospitalet ( Site 0576), Copenhagen, Hovedstaden

Odense Universitetshospital-Department of oncology ( Site 0579), Odense, Syddanmark

Vejle Sygehus ( Site 0578), Vejle, Syddanmark

Tampereen yliopistollinen sairaala ( Site 0604), Tampere, Pirkanmaa

Kuopion Yliopistollinen Sairaala ( Site 0603), Kuopio, Pohjois-Savo

Turku University Hospital-Department of Oncology ( Site 0601), Turku, Varsinais-Suomi

Institut de cancérologie Strasbourg Europe (ICANS) ( Site 0627), Strasbourg, Alsace

Centre Hospitalier Universitaire de Nîmes - Institut de Cancérologie du Gard - Hôpital Universitaire ( Site 0630), Nîmes, Gard

Centre Eugène Marquis Rennes - Centre de Lutte Contre le Cancer ( Site 0632), Rennes, Ille-et-Vilaine

Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne ( Site 0629), Clermont-Ferrand, Puy-de-Dome

Centre Hospitalier de la Côte Basque ( Site 0633), Bayonne, Pyrenees-Atlantiques

Gustave Roussy ( Site 0626), Villejuif, Val-de-Marne

Hôpital Européen Georges Pompidou ( Site 0628), Paris, Not set

klinikum rechts der isar der technischen universität münchen-Urologische Klinik und Poliklinik ( Site 0696), Munich, Bayern

HELIOS Kliniken Schwerin ( Site 0694), Schwerin, Mecklenburg-Vorpommern

Universitätsklinikum Bonn-Klinik und Poliklinik für Urologie und Kinderurologie ( Site 0680), Bonn, Nordrhein-Westfalen

Universitätsklinikum Münster - Albert Schweitzer Campus-Klinik für Urologie ( Site 0678), Münster, Nordrhein-Westfalen

Universitätsklinikum Schleswig-Holstein-Klinik für Urologie ( Site 0691), Lubeck, Schleswig-Holstein

Universitätsklinikum Jena-Klinik und Poliklinik für Urologie ( Site 0682), Jena, Thuringen

Charité Universitaetsmedizin Berlin - Campus Mitte ( Site 0679), Berlin, Not set

Universitaetsklinikum Hamburg-Eppendorf-Onkologisches Zentrum ( Site 0705), Hamburg, Not set

Queen Mary Hospital ( Site 0727), Hong Kong, Not set

Prince of Wales Hospital ( Site 0730), Shatin, Not set

Bacs-Kiskun Varmegyei Oktatokorhaz-Onkoradiologiai Kozpont ( Site 0752), Kecskemét, Bacs-Kiskun

Nograd Varmegyei Szent Lazar Korhaz-Onkologia es Sugarterapias Osztaly ( Site 0761), Salgótarján, Nograd

Országos Onkológiai Intézet-Urogenitális Tumorok és Klinikai Farmakológiai Osztály ( Site 0756), Budapest, Pest

Debreceni Egyetem Klinikai Kozpont-Onkológiai Klinika ( Site 0758), Debrecen, Not set

St. Vincent's University Hospital ( Site 0802), Dublin 04, Dublin

Tallaght University Hospital ( Site 0801), Dublin, Not set

Emek Medical Center ( Site 0830), Afula, Not set

Rambam Health Care Campus-Oncology Division ( Site 0826), Haifa, Not set

Hadassah Medical Center ( Site 0833), Jerusalem, Not set

Meir Medical Center. ( Site 0832), Kfar Saba, Not set

Rabin Medical Center ( Site 0828), Petah Tikva, Not set

Sheba Medical Center ( Site 0827), Ramat Gan, Not set

IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"-Oncologia Medica ( Site 0879), Meldola, Emilia-Romagna

Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 0877), Milan, Lombardia

Ospedale San Raffaele-Oncologia Medica ( Site 0876), Milano, Not set

Toho University Sakura Medical Center ( Site 0906), Sakura, Chiba

Ehime University Hospital ( Site 0918), Toon, Ehime

Hospital of the University of Occupational and Environmental Health, Japan ( Site 0921), Kitakyushu, Fukuoka

Kurume University Hospital ( Site 0920), Kurume, Fukuoka

Asahikawa Medical University Hospital ( Site 0901), Asahikawa, Hokkaido

Sapporo Medical University Hospital ( Site 0902), Sapporo, Hokkaido

Hokkaido University Hospital ( Site 0931), Sapporo, Hokkaido

Kobe University Hospital ( Site 0914), Kobe, Hyogo

Kanazawa Medical University Hospital ( Site 0909), Uchinada, Ishikawa

Kagawa University Hospital ( Site 0917), Kita, Kagawa

Yokohama City University Medical Center ( Site 0908), Yokohama, Kanagawa

National Hospital Organization Nagasaki Medical Center ( Site 0923), Ōmura, Nagasaki

Nara Medical University Hospital ( Site 0915), Kashihara, Nara

Nanbu Tokushukai Hospital ( Site 0930), Shimajiri, Okinawa

Kansai Medical University Hospital ( Site 0912), Hirakata, Osaka

Bell Land General Hospital ( Site 0913), Sakai, Osaka

The University of Osaka Hospital ( Site 0911), Suita, Osaka

Saga-Ken Medical Centre Koseikan ( Site 0922), Saga-shi, Saga

The Jikei University Hospital ( Site 0907), Minato, Tokyo

Akita University Hospital ( Site 0904), Akita, Not set

Kyushu University Hospital ( Site 0919), Fukuoka, Not set

Fukushima Medical University Hospital ( Site 0933), Fukushima, Not set

Gifu University Hospital ( Site 0910), Gifu, Not set

Hiroshima University Hospital ( Site 0916), Hiroshima, Not set

Kagoshima University Hospital ( Site 0929), Kagoshima, Not set

National Hospital Organization Kumamoto Medical Center ( Site 0924), Kumamoto, Not set

Miyazaki Prefectural Miyazaki Hospital ( Site 0927), Miyazaki, Not set

University of Miyazaki Hospital ( Site 0926), Miyazaki, Not set

Nagano Municipal Hospital ( Site 0932), Nagano, Not set

National Hospital Organization Oita Medical Center ( Site 0925), Oita, Not set

Asan Medical Center-Oncology ( Site 1402), Songpagu, Seoul

Seoul National University Hospital-Oncology ( Site 1401), Seoul, Not set

Severance Hospital, Yonsei University Health System-Medical oncology ( Site 1404), Seoul, Not set

Samsung Medical Center ( Site 1405), Seoul, Not set

Hospital Sultan Ismail ( Site 1081), Johor Bahru, Johor

University Malaya Medical Centre ( Site 1077), Lembah Pantai, Kuala Lumpur

Sarawak General Hospital-Radiotherapy Unit ( Site 1076), Kuching, Sarawak

National Cancer Institute ( Site 1079), Putrajaya, Wilayah Persekutuan Putrajaya

Hospital Kuala Lumpur-Radiotherapy and Oncology ( Site 1078), Kuala Lumpur, Not set

Quemex Medical and Research ( Site 1112), Mexico City, Distrito Federal

CIO - Centro de Inmuno-Oncología de Occidente ( Site 1103), Guadalajara, Jalisco

Filios Alta Medicina ( Site 1106), Monterrey, Nuevo Leon

Medical Care and Research SA de CV ( Site 1108), Merida, Yucatan

Centro de Investigacion Clinica de Oaxaca ( Site 1109), Oaxaca, Not set

Medische Centrum Leeuwarden ( Site 1172), Leeuwarden, Fryslan

Radboudumc-Medical Oncology ( Site 1152), Nijmegen, Gelderland

Zuyderland Medical Centre-Trialbureau Interne Geneeskunde ( Site 1163), Sittard-Geleen, Limburg

VieCuri Medisch Centrum ( Site 1173), Venlo, Limburg

ETZ Elisabeth-Internal Medicine ( Site 1160), Tilburg, Noord-Brabant

Nederlands Kanker Instituut - Antoni van Leeuwenhoek - NKI-AVL ( Site 1153), Amsterdam, Noord-Holland

Amsterdam UMC, locatie VUmc ( Site 1156), Amsterdam, Noord-Holland

Spaarne Gasthuis - Hoofddorp-Oncology ( Site 1170), Hoofddorp, Noord-Holland

Meander Medisch Centrum ( Site 1157), Amersfoort, Utrecht

Haga Ziekenhuis locatie Leyweg-Oncology ( Site 1164), Den Haag, Zuid-Holland

Franciscus Gasthuis & Vlietland, Locatie Vlietland ( Site 1151), Schiedam, Zuid-Holland

Tauranga Hospital-Bay of Plenty Clinical Trials Unit ( Site 1201), Tauranga, Bay Of Plenty

Dunedin Hospital-Southern Blood and Cancers Service ( Site 1203), Dunedin, Otago

Akershus Universitetssykehus-Onkologisk avdeling ( Site 1227), Lørenskog, Akershus

Sykehuset Østfold Kalnes ( Site 1228), Sarpsborg, Ostfold

St. Olavs Hospital-Kreftklinikken ( Site 1231), Trondheim, Sor-Trondelag

Instituto Regional de Enfermedades Neoplasicas del Centro (IREN CENTRO) ( Site 1258), Concepcion, Junin

Clínica Sánchez Ferrer ( Site 1261), Trujillo, La Libertad

Aliada-Oncologìa ( Site 1257), Lima, Not set

IPOR Instituto Peruano de Oncología & Radioterapia-Centro de Investigación ( Site 1254), Lima, Not set

Oncosalud-Clinical Research ( Site 1260), Lima, Not set

INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS-Medical Oncology ( Site 1256), Lima, Not set

Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 1302), Bydgoszcz, Kujawsko-pomorskie

Regionalny Szpital Specjalistyczny im. dr. Władyslawa Biegańskiego ( Site 1316), Grudziadz, Kujawsko-pomorskie

Wojewodzki Szpital Zespolony im Ludwika Rydygiera w Toruniu ( Site 1304), Torun, Kujawsko-pomorskie

Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 1310), Siedlce, Mazowieckie

Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zakl-Klinika Onkologii Klinicznej, Dzial Ch ( Site 1318), Kielce, Swietokrzyskie

Szpital Wojewódzki im. Mikoaja Kopernika w Koszalinie-Oddzial Dzienny Chemioterapii ( Site 1303), Koszalin, Zachodniopomorskie

Zachodniopomorskie Centrum Onkologii ( Site 1311), Szczecin, Zachodniopomorskie

Puerto Rico Medical Research Center LLC ( Site 1354), Hato Rey, Not set

Ad-Vance Medical Research-Research ( Site 1353), Ponce, Not set

Pan American Center for Oncology Trials - Ciudadela ( Site 1351), San Juan, Not set

National University Hospital ( Site 1376), Singapore, Central Singapore

National Cancer Centre Singapore ( Site 1377), Singapore, Central Singapore

Tan Tock Seng Hospital-Medical Oncology ( Site 1378), Singapore, Central Singapore

Hospital Jerez de la Frontera ( Site 1427), Jerez de la Frontera, Cadiz

Hospital Universitario Ramón y Cajal-Medical Oncology ( Site 1431), Madrid, Madrid, Comunidad De

Hospital Universitario 12 de Octubre-Medical Oncology ( Site 1433), Madrid, Madrid, Comunidad De

Complexo Hospitalario Universitario de Ourense ( Site 1426), Ourense, Orense

Fundación Instituto Valenciano de Oncología-Oncologico ( Site 1430), Valencia, Valenciana, Comunitat

Hospital Lucus Augusti-Oncology ( Site 1432), Lugo, Not set

HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO-Medical Oncology ( Site 1428), Sevilla, Not set

Karolinska Universitetssjukhuset Solna ( Site 1478), Stockholm, Stockholms Lan

Akademiska sjukhuset-Blod- och tumörsjukdomar ( Site 1477), Uppsala, Uppsala Lan

Sahlgrenska Universitetssjukhuset ( Site 1479), Gothenburg, Vastra Gotalands Lan

China Medical University Hospital-Department of Urology ( Site 1503), Taichung, Not set

National Cheng Kung University Hospital-Urology ( Site 1502), Tainan, Not set

National Taiwan University Hospital-Urology ( Site 1506), Taipei, Not set

Taipei Veterans General Hospital ( Site 1505), Taipei, Not set

Chang Gung Medical Foundation-Linkou Branch-Medical Oncology ( Site 1504), Taoyuan, Not set

Faculty of Medicine - Khon Kaen University ( Site 1526), Muang, Khon Kaen

Chulalongkorn University ( Site 1530), Bangkok, Krung Thep Maha Nakhon

Faculty of Medicine Siriraj Hospital ( Site 1531), Bangkok, Krung Thep Maha Nakhon

Songklanagarind hospital ( Site 1527), Hatyai, Songkhla

Baskent University Dr. Turgut Noyan Research and Training Center-ONCOLOGY ( Site 1554), Adana, Not set

Gulhane Egitim Arastirma Hastanesi ( Site 1558), Ankara, Not set

Hacettepe Universite Hastaneleri-oncology hospital ( Site 1551), Ankara, Not set

Memorial Ankara Hastanesi-Medical Oncology ( Site 1557), Ankara, Not set

Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 1552), Ankara, Not set

Istanbul Universitesi Cerrahpasa-Medical Oncology ( Site 1555), Istanbul, Not set

TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 1553), Istanbul, Not set

Addenbrooke's Hospital ( Site 1605), Cambridge, Cambridgeshire

The Royal Cornwall Hospital ( Site 1610), Truro, England

The Beatson West of Scotland Cancer Centre ( Site 1603), Glasgow, Glasgow City

Charing Cross Hospital-Oncology Research ( Site 1606), London, Hammersmith And Fulham

University College London Hospital ( Site 1612), London, London, City Of

The Christie NHS Foundation Trust ( Site 1608), Manchester, Not set

Conditions: Prostate Cancer Metastatic

Learn More ›

Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis

NCT05451771

Recruiting

The purpose of this study is assess safety, safest dose, and effectiveness of venetoclax in combination with dexamethasone in participants with t(11;14) positive relapsed (comes back) or refractory (did not get better) light chain amyloidosis.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/03/2025

Locations: Boston Medical Center, Boston, Massachusetts +3 locations

Conditions: AL Amyloidosis

Learn More ›

A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition

NCT05787574

Recruiting

The researchers are doing this study to find out whether emapalumab or a combination of fludarabine and dexamethasone are effective in preparing people with a primary immune regulatory disorder (PIRD) and/or an autoinflammatory condition to receive a stem cell transplant. The researchers will look at how well the study treatments reduce inflammation and aid in the engraftment process (the process of donated stem cells traveling to the bone marrow, where they begin to make new immune cells. "Fun... Read More

Gender:

ALL

Ages:

All

Trial Updated:

07/03/2025

Locations: University of California, San Francisco (Data collection only), San Francisco, California +10 locations

Conditions: Primary Immune Regulatory Disorder, Autoimmune Lymphoproliferative, Immune System Diseases

Learn More ›

MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma

NCT05090566

Recruiting

The purpose of this study is to determine the Recommended Phase 2 Dose and clinical benefit of elranatamab in combination with other anti-cancer therapies in participants with multiple myeloma.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/02/2025

Locations: Banner Gateway Medical Center, Gilbert, Arizona +28 locations

Banner Gateway Medical Center, Gilbert, Arizona

Banner Gateway Medical Pavilion, Gilbert, Arizona

Banner MD Anderson Cancer Center, Gilbert, Arizona

University of Arkansas for Medical Sciences - Winthrop P. Rockefeller Cancer Institute, Little Rock, Arkansas

Beverly Hills Cancer Center, Beverly Hills, California

Clinical Research Advisors, Encino, California

Clinical Research Advisors, Los Angeles, California

Cedars Sinai Medical Center Oncology IDS Pharmacy Attn:Suwicha Limvorasak ,PharmaD, Los Angeles, California

Cedars Sinai Medical Center, Los Angeles, California

Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute (SOCCI), Los Angeles, California

Clinical Research Advisors, Los Angeles, California

Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center, Coral Gables, Florida

Sylvester Comprehensive Cancer Center- Deerfield Beach, Deerfield Beach, Florida

Sylvester Comprehensive Cancer Center, Miami, Florida

UHealth Tower, Miami, Florida

UChicago Medicine - River East, Chicago, Illinois

University of Chicago Medical Center, Chicago, Illinois

UChicago Medicine at Ingalls - Flossmoor, Flossmoor, Illinois

UChicago Medicine Ingalls Memorial, Harvey, Illinois

University of Chicago Comprehensive Cancer Center at Silver Cross Hospital, New Lenox, Illinois

The University of Chicago Medicine Center for Advanced Care Orland Park, Orland Park, Illinois

UChicago Medicine at Ingalls - Tinley Park, Tinley Park, Illinois

OIDS, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (Also Imaging Facility), Baltimore, Maryland

Massachusetts General Hospital, Boston, Massachusetts

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Arthur J.E. Child Comprehensive Cancer Centre, Calgary, Alberta

The Ottawa Hospital - General Campus, Ottawa, Ontario

Princess Margaret Cancer Centre, Toronto, Ontario

Conditions: Multiple Myeloma

Learn More ›

Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma

NCT01745588

Active Not Recruiting

The purpose of this study is to see whether pomalidomide (also known as Pomalyst) reduces the number of myeloma cells in the bones, and to see what is the best way to use pomalidomide in patients with myeloma. To do this, the investigators want to compare two types of treatment using pomalidomde. This is a randomized trial which means that the decision as to which treatment the patient will receive will be made by a computer, much like flipping a coin. All patients start by receiving 4 cycles o... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/02/2025

Locations: Memorial Sloan Kettering Cancer Center, Basking Ridge, New Jersey +9 locations

Conditions: Multiple Myeloma

Learn More ›

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

NCT04546399

Recruiting

This phase II trial studies the effect of nivolumab in combination with blinatumomab compared to blinatumomab alone in treating patients with B-cell acute lymphoblastic leukemia (B-ALL) that has come back (relapsed). Down syndrome patients with relapsed B-ALL are included in this study. Blinatumomab is an antibody, which is a protein that identifies and targets specific molecules in the body. Blinatumomab searches for and attaches itself to the cancer cell. Once attached, an immune response occu... Read More

Gender:

ALL

Ages:

Between 1 year and 30 years

Trial Updated:

07/01/2025

Locations: Children's Hospital of Alabama, Birmingham, Alabama +207 locations

Children's Hospital of Alabama, Birmingham, Alabama

USA Health Strada Patient Care Center, Mobile, Alabama

Providence Alaska Medical Center, Anchorage, Alaska

Kingman Regional Medical Center, Kingman, Arizona

Banner Children's at Desert, Mesa, Arizona

Banner University Medical Center - Tucson, Tucson, Arizona

Arkansas Children's Hospital, Little Rock, Arkansas

Kaiser Permanente-Anaheim, Anaheim, California

PCR Oncology, Arroyo Grande, California

Kaiser Permanente-Bellflower, Bellflower, California

Kaiser Permanente Downey Medical Center, Downey, California

City of Hope Comprehensive Cancer Center, Duarte, California

Kaiser Permanente-Fontana, Fontana, California

Loma Linda University Medical Center, Loma Linda, California

Children's Hospital Los Angeles, Los Angeles, California

Kaiser Permanente Los Angeles Medical Center, Los Angeles, California

Cedars Sinai Medical Center, Los Angeles, California

Mattel Children's Hospital UCLA, Los Angeles, California

Valley Children's Hospital, Madera, California

Kaiser Permanente-Oakland, Oakland, California

Children's Hospital of Orange County, Orange, California

Lucile Packard Children's Hospital Stanford University, Palo Alto, California

Sutter Medical Center Sacramento, Sacramento, California

University of California Davis Comprehensive Cancer Center, Sacramento, California

Kaiser Permanente-San Diego Zion, San Diego, California

Rady Children's Hospital - San Diego, San Diego, California

UCSF Medical Center-Mission Bay, San Francisco, California

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California

Children's Hospital Colorado, Aurora, Colorado

Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver, Colorado

Connecticut Children's Medical Center, Hartford, Connecticut

Yale University, New Haven, Connecticut

Alfred I duPont Hospital for Children, Wilmington, Delaware

Children's National Medical Center, Washington, District of Columbia

Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida

University of Florida Health Science Center - Gainesville, Gainesville, Florida

Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida

Nemours Children's Clinic-Jacksonville, Jacksonville, Florida

AdventHealth Orlando, Orlando, Florida

Arnold Palmer Hospital for Children, Orlando, Florida

Nemours Children's Hospital, Orlando, Florida

Sacred Heart Hospital, Pensacola, Florida

Johns Hopkins All Children's Hospital, Saint Petersburg, Florida

Tampa General Hospital, Tampa, Florida

Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa, Florida

Saint Mary's Medical Center, West Palm Beach, Florida

Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta, Georgia

Memorial Health University Medical Center, Savannah, Georgia

Kapiolani Medical Center for Women and Children, Honolulu, Hawaii

Saint Luke's Cancer Institute - Boise, Boise, Idaho

Lurie Children's Hospital-Chicago, Chicago, Illinois

University of Illinois, Chicago, Illinois

University of Chicago Comprehensive Cancer Center, Chicago, Illinois

Loyola University Medical Center, Maywood, Illinois

Saint Jude Midwest Affiliate, Peoria, Illinois

Riley Hospital for Children, Indianapolis, Indiana

Blank Children's Hospital, Des Moines, Iowa

University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa

University of Kentucky/Markey Cancer Center, Lexington, Kentucky

Norton Children's Hospital, Louisville, Kentucky

Children's Hospital New Orleans, New Orleans, Louisiana

Ochsner Medical Center Jefferson, New Orleans, Louisiana

Maine Children's Cancer Program, Scarborough, Maine

Sinai Hospital of Baltimore, Baltimore, Maryland

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland

Walter Reed National Military Medical Center, Bethesda, Maryland

Tufts Children's Hospital, Boston, Massachusetts

C S Mott Children's Hospital, Ann Arbor, Michigan

Bronson Battle Creek, Battle Creek, Michigan

Corewell Health Dearborn Hospital, Dearborn, Michigan

Children's Hospital of Michigan, Detroit, Michigan

Michigan State University Clinical Center, East Lansing, Michigan

Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids, Michigan

Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids, Michigan

Trinity Health Grand Rapids Hospital, Grand Rapids, Michigan

Bronson Methodist Hospital, Kalamazoo, Michigan

West Michigan Cancer Center, Kalamazoo, Michigan

Ascension Borgess Hospital, Kalamazoo, Michigan

Trinity Health Muskegon Hospital, Muskegon, Michigan

Corewell Health Lakeland Hospitals - Niles Hospital, Niles, Michigan

Cancer and Hematology Centers of Western Michigan - Norton Shores, Norton Shores, Michigan

Corewell Health Reed City Hospital, Reed City, Michigan

Corewell Health Children's, Royal Oak, Michigan

Corewell Health William Beaumont University Hospital, Royal Oak, Michigan

Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center, Saint Joseph, Michigan

Corewell Health Lakeland Hospitals - Saint Joseph Hospital, Saint Joseph, Michigan

Munson Medical Center, Traverse City, Michigan

Corewell Health Beaumont Troy Hospital, Troy, Michigan

University of Michigan Health - West, Wyoming, Michigan

Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis, Minnesota

University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota

University of Mississippi Medical Center, Jackson, Mississippi

Children's Mercy Hospitals and Clinics, Kansas City, Missouri

Cardinal Glennon Children's Medical Center, Saint Louis, Missouri

Washington University School of Medicine, Saint Louis, Missouri

Mercy Hospital Saint Louis, Saint Louis, Missouri

Children's Hospital and Medical Center of Omaha, Omaha, Nebraska

University of Nebraska Medical Center, Omaha, Nebraska

Carson Tahoe Regional Medical Center, Carson City, Nevada

Comprehensive Cancer Centers of Nevada - Henderson, Henderson, Nevada

Comprehensive Cancer Centers of Nevada-Horizon Ridge, Henderson, Nevada

Las Vegas Cancer Center-Henderson, Henderson, Nevada

OptumCare Cancer Care at Seven Hills, Henderson, Nevada

Comprehensive Cancer Centers of Nevada-Southeast Henderson, Henderson, Nevada

OptumCare Cancer Care at Charleston, Las Vegas, Nevada

Hope Cancer Care of Nevada, Las Vegas, Nevada

Sunrise Hospital and Medical Center, Las Vegas, Nevada

Ann M Wierman MD LTD, Las Vegas, Nevada

Comprehensive Cancer Centers of Nevada - Northwest, Las Vegas, Nevada

OptumCare Cancer Care at MountainView, Las Vegas, Nevada

Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada

Comprehensive Cancer Centers of Nevada - Town Center, Las Vegas, Nevada

Comprehensive Cancer Centers of Nevada-Summerlin, Las Vegas, Nevada

Summerlin Hospital Medical Center, Las Vegas, Nevada

Las Vegas Cancer Center-Medical Center, Las Vegas, Nevada

Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada

OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada

Comprehensive Cancer Centers of Nevada - Central Valley, Las Vegas, Nevada

Hope Cancer Care of Nevada-Pahrump, Pahrump, Nevada

Renown Regional Medical Center, Reno, Nevada

Saint Mary's Regional Medical Center, Reno, Nevada

Cancer Care Specialists - Reno, Reno, Nevada

Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire

Hackensack University Medical Center, Hackensack, New Jersey

Morristown Medical Center, Morristown, New Jersey

Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick, New Jersey

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey

Newark Beth Israel Medical Center, Newark, New Jersey

Saint Joseph's Regional Medical Center, Paterson, New Jersey

Albany Medical Center, Albany, New York

Montefiore Medical Center - Moses Campus, Bronx, New York

Maimonides Medical Center, Brooklyn, New York

NYU Langone Hospital - Long Island, Mineola, New York

The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park, New York

Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York

Memorial Sloan Kettering Cancer Center, New York, New York

University of Rochester, Rochester, New York

Stony Brook University Medical Center, Stony Brook, New York

State University of New York Upstate Medical University, Syracuse, New York

UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina

Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina

Duke University Medical Center, Durham, North Carolina

East Carolina University, Greenville, North Carolina

Wake Forest University Health Sciences, Winston-Salem, North Carolina

Sanford Broadway Medical Center, Fargo, North Dakota

Children's Hospital Medical Center of Akron, Akron, Ohio

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

Rainbow Babies and Childrens Hospital, Cleveland, Ohio

Cleveland Clinic Foundation, Cleveland, Ohio

Nationwide Children's Hospital, Columbus, Ohio

Dayton Children's Hospital, Dayton, Ohio

ProMedica Flower Hospital, Sylvania, Ohio

ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo, Ohio

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Legacy Emanuel Children's Hospital, Portland, Oregon

Oregon Health and Science University, Portland, Oregon

Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania

Geisinger Medical Center, Danville, Pennsylvania

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Saint Christopher's Hospital for Children, Philadelphia, Pennsylvania

Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania

Rhode Island Hospital, Providence, Rhode Island

Prisma Health Richland Hospital, Columbia, South Carolina

BI-LO Charities Children's Cancer Center, Greenville, South Carolina

Prisma Health Cancer Institute - Eastside, Greenville, South Carolina

Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota

East Tennessee Childrens Hospital, Knoxville, Tennessee

The Children's Hospital at TriStar Centennial, Nashville, Tennessee

Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee

Dell Children's Medical Center of Central Texas, Austin, Texas

Driscoll Children's Hospital, Corpus Christi, Texas

Medical City Dallas Hospital, Dallas, Texas

UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas

El Paso Children's Hospital, El Paso, Texas

Cook Children's Medical Center, Fort Worth, Texas

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas

Children's Hospital of San Antonio, San Antonio, Texas

Methodist Children's Hospital of South Texas, San Antonio, Texas

University of Texas Health Science Center at San Antonio, San Antonio, Texas

Primary Children's Hospital, Salt Lake City, Utah

University of Vermont and State Agricultural College, Burlington, Vermont

Inova Fairfax Hospital, Falls Church, Virginia

Children's Hospital of The King's Daughters, Norfolk, Virginia

Overlake Medical Center, Bellevue, Washington

Valley Medical Center, Renton, Washington

Seattle Children's Hospital, Seattle, Washington

Providence Sacred Heart Medical Center and Children's Hospital, Spokane, Washington

Mary Bridge Children's Hospital and Health Center, Tacoma, Washington

Madigan Army Medical Center, Tacoma, Washington

North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima, Washington

United Hospital Center, Bridgeport, West Virginia

WVUH-Berkely Medical Center, Martinsburg, West Virginia

West Virginia University Healthcare, Morgantown, West Virginia

Camden Clark Medical Center, Parkersburg, West Virginia

University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin

Children's Hospital of Wisconsin, Milwaukee, Wisconsin

John Hunter Children's Hospital, Hunter Regional Mail Centre, New South Wales

Sydney Children's Hospital, Randwick, New South Wales

The Children's Hospital at Westmead, Westmead, New South Wales

Queensland Children's Hospital, South Brisbane, Queensland

Perth Children's Hospital, Perth, Western Australia

CancerCare Manitoba, Winnipeg, Manitoba

IWK Health Centre, Halifax, Nova Scotia

The Montreal Children's Hospital of the MUHC, Montreal, Quebec

Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec

CHU de Quebec-Centre Hospitalier de l'Universite Laval (CHUL), Quebec, Not set

University Pediatric Hospital, San Juan, Not set

Conditions: Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia

Learn More ›

Browse by State

Dexamethasone treatment options in Alabama

Dexamethasone treatment options in Alaska

Dexamethasone treatment options in Arizona

Dexamethasone treatment options in Arkansas

Dexamethasone treatment options in California

Dexamethasone treatment options in Colorado

Dexamethasone treatment options in Connecticut

Dexamethasone treatment options in Delaware

Dexamethasone treatment options in District of Columbia

Dexamethasone treatment options in Florida

Dexamethasone treatment options in Georgia

Dexamethasone treatment options in Hawaii

Dexamethasone treatment options in Idaho

Dexamethasone treatment options in Illinois

Dexamethasone treatment options in Indiana

Dexamethasone treatment options in Iowa

Dexamethasone treatment options in Kansas

Dexamethasone treatment options in Kentucky

Dexamethasone treatment options in Louisiana

Dexamethasone treatment options in Maine

Dexamethasone treatment options in Montana

Dexamethasone treatment options in Nebraska

Dexamethasone treatment options in Nevada

Dexamethasone treatment options in New Hampshire

Dexamethasone treatment options in New Jersey

Dexamethasone treatment options in New Mexico

Dexamethasone treatment options in New York

Dexamethasone treatment options in North Carolina

Dexamethasone treatment options in North Dakota

Dexamethasone treatment options in Ohio

Dexamethasone treatment options in Oklahoma

Dexamethasone treatment options in Oregon

Dexamethasone treatment options in Maryland

Dexamethasone treatment options in Massachusetts

Dexamethasone treatment options in Michigan

Dexamethasone treatment options in Minnesota

Dexamethasone treatment options in Mississippi

Dexamethasone treatment options in Missouri

Dexamethasone treatment options in Pennsylvania

Dexamethasone treatment options in Rhode Island

Dexamethasone treatment options in South Carolina

Dexamethasone treatment options in South Dakota

Dexamethasone treatment options in Tennessee

Dexamethasone treatment options in Texas

Dexamethasone treatment options in Utah

Dexamethasone treatment options in Vermont

Dexamethasone treatment options in Virginia

Dexamethasone treatment options in Washington

Dexamethasone treatment options in West Virginia

Dexamethasone treatment options in Wisconsin

Dexamethasone treatment options in Wyoming